Guanine

Guanine

SCHEMBL7255284

Nc1nc2nc[nH]c2c(=O)[nH]1.OP(O)(O)=S

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PNP P00491 2/20 0.81
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
MAPT P10636 1/20 0.51
THRB P10828 1/20 0.51
HPGD P15428 1/20 0.51
KMT2A Q03164 1/20 0.51
HSD17B10 Q99714 1/20 0.51
GDA Q9Y2T3 1/20 0.48
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46
GRIA3 P42263 1/20 0.46
GRIA4 P48058 1/20 0.46
XDH P47989 1/20 0.45
DPP4 P27487 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL28445236 0.97 PNP (0.77) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL101895 0.92 PNP (0.84) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL76056 0.92 PNP (0.84) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL663746 0.92 PNP (0.84) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL5372458 0.91 PNP (0.81) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL1264884 0.90 PNP (1.00) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL5260 0.90 PNP (1.00) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL986801 0.90 PNP (1.00) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL28840730 0.89 PNP (0.79) PNPALDH1A1KDM4EMEN1MAPT
Guanine SCHEMBL27542047 0.89 PNP (0.90) PNPALDH1A1KDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380897-B1 RNAi modulation of ApoB and uses thereof ALNYLAM PHARMACEUTICALS INC (US) 2015-05-13 EP disclosed
EP-2377873-B1 RNAi modulation of ApoB and uses thereof ALNYLAM PHARMACEUTICALS INC (US) 2014-08-20 EP disclosed
CN-101133074-A RNAi modulation of APOB and uses thereof ALNYLAM PHARMACEUTICALS INC (US) 2008-02-27 CN disclosed
EP-1267923-A1 USE OF ALIPHATIC QUATERNARY AMMONIUM AS ADJUVANT IN A PHARMACEUTICAL COMPOSITION ADMINISTERED BY MUCOSAL DELIVERY PIERRE FABRE MEDICAMENT (FR) 2003-01-02 EP disclosed
WO-2001074387-A1 USE OF ALIPHATIC QUATERNARY AMMONIUM AS ADJUVANT IN A PHARMACEUTICAL COMPOSITION ADMINISTERED BY MUCOSAL DELIVERY PIERRE FABRE MEDICAMENT (FR) 2001-10-11 WO disclosed